MutantDx Technologies

The various patents have been variously combined into processes that are specific for particular clinical applications. They are listed below:

TumorPlex and ASMS

Detection of SNPs from tissue or liquid biopsy samples

PrimaCap

Detecting mutations in small DNA fragments from tissue and liquid biopsy samples

SeqVar

Predicting drug efficacy for treatment with Check Point Inhibitors

RepSeqID and MSI

Detection of deletion/insertion and fusion mutations

Contact MutantDx

info@MutantDx.com

001-780-885-4257